NCT07325916 · COMPLETED
Relationship Between Serum Apolipoprotein Levels and Weight Loss in Patients Undergoing Sleeve Gastrectomy for Morbid Obesity
This study is examining whether blood levels of a protein called apolipoprotein can predict how much weight someone loses after sleeve gastrectomy, a surgery that reduces stomach size. Researchers want to find a specific protein threshold that helps doctors decide who benefits most from surgery versus non-surgical approaches. The phase is unspecified, suggesting this is likely an observational study rather than a drug or device trial.
You may qualify if
- Patients aged 18 to 75
- International Classification of Diseases (ICD) code E66 diagnosis (obesity)
- Patients who have given consent for sleeve gastrectomy
- Patients who are suitable for general anesthesia
You're excluded if
- Patients who did not give consent to be included in the study
- Patients who are scheduled for surgery other than sleeve gastrectomy
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-08-17